5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[b]pyrazine | 1062322-70-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[b]pyrazine
• CAS: 1062322-70-6
• 化学式: C₁₄H₂₂N₂
• 分子量: 218.342
• InChiKey: JKJGBAJYMCTKIW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Organic Compounds
  申请人：Schilling Boris

  公开号：US20100113460A1

  公开（公告）日：2010-05-06

  Disclosed are compounds having the ability to inhibit cytochrome P450 2A6, 2A13, and/or 2B6 and tobacco products comprising them. Also disclosed are pharmaceutical compositions comprising them.

  揭示了一种具有抑制细胞色素P450 2A6、2A13和/或2B6能力的化合物，以及包含它们的烟草产品。还披露了包含这些化合物的药物组合物。
• ORGANIC COMPOUNDS
  申请人：Givaudan SA

  公开号：EP2139354A2

  公开（公告）日：2010-01-06
• Polyolefin Resin Composition and Electric Wire Using the Same
  申请人：Kodama Koji

  公开号：US20080300342A1

  公开（公告）日：2008-12-04

  A polyolefin resin composition excellent in flame retardancy and mechanical properties and also in wearing resistance and an electric wire produced with the composition are provided. The polyolefin resin composition is characterized by containing, as a flame retardant, magnesium hydroxide particles which have a higher fatty acid bonded to part of the surface of the particles and further have a silicone oil having reactivity bonded to that part of the particles which does not have the higher fatty acid bonded thereto. The electric wire is characterized by having a sheath layer formed from the polyolefin resin composition.
• [EN] ORGANIC COMPOUNDS<br/>[FR] COMPOSÉS ORGANIQUES
  申请人：GIVAUDAN SA

  公开号：WO2008116339A2

  公开（公告）日：2008-10-02

  [EN] Disclosed are compounds having the ability to inhibit cytochrome P450 2A6, 2A13, and/or 2B6 and tobacco products comprising them. Also disclosed are pharmaceutical compositions comprising them.
  [FR] L'invention concerne des composés capables d'inhiber le cytochrome P450 2A6, 2A13 et/ou 2B6 ainsi que des produits du tabac les comprenant. L'invention concerne également des compositions pharmaceutiques les comprenant.